chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning an adult patient who on 02-NOV-2005 was vaccinated with pneumococcal 23v polysaccharide (0.5 ml) (subcutaneous) (Lot#649912/0529P).  On 02-NOV-2005 the patient experienced injection site soreness, warmth, erythema, swelling and general malaise.  The patient was considered to be recovering.  Unspecified medical attention was sought.  Attempts are being made to obtain additional information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.
A non-serious spontaneous report of we gave the full dose of FLUMIST (0.2 ML) into one nostril was received from a nurse concerning a five-year-old female. No medical history nor concomitant medications were reported. On 22-Oct-2009, the patient received the entire 0.2ml FLUMIST dose in one nostril. There was no adverse event associated with this vaccination error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
DATE OF ADMISSION:  07/21/2022 DATE OF DISCHARGE:  07/27/2022   HOSPITAL COURSE The patient is a very pleasant 71-year-old male with past medical history as listed above including esophageal adenocarcinoma on trial drug who presented to Hospital with vague complaints of feeling progressively weak with excessive cough, difficulty eating secondary to mouth sores.  Initial laboratory studies and imaging can be found per review.  The patient was pancytopenic.  The patient was placed in severe respiratory isolation given recent diagnosis of COVID and COVID positive test on presentation.  Chest x-ray showed right basilar atelectasis versus pneumonitis.  He was empirically treated with cefepime.  Procalcitonin and lactic acid were within normal limits.  He was stable on room air.  He did complete remdesivir while hospitalized.  The patient had complaints of hallucinations prior to admission, and a CT head on 07/21 showed deep white matter left occipital mass or metastasis.  He underwent MRI of the brain on July 22 showing rim enhancing nodule with vasogenic edema concerning for metastatic disease.  He was placed on IV Decadron.  Neurosurgery was consulted.  No surgical intervention recommended.  Radiation Oncology was recommended, who evaluated the patient and is planning simulation and RT as an outpatient.  For his mucositis, he was treated with Collin solution, BMX, lidocaine, and nystatin.  Palliative Care was consulted to assist with pain control.  For his right hand wound, Wound was consulted who recommended moisturizing the area.  In terms of his esophageal adenocarcinoma, given new brain metastasis, he is now off trial, but does have other therapy options that will be considered in the future when the patient's nutrition and functional status improve.  Physical, Occupational, and Nutritional Therapy were consulted, who recommended home at discharge with outpatient PT, OT.  Care Management was consulted to facilitate discharge planning.  He was felt medically stable for discharge on 07/27/2022.
Pt. began typoid oral medication on 5/26/15- slight upset stomach that increased with each pill. 6/1/15 became dizzy sharp stomach pains, nausea and then passed out. Someone called-pt passed out again taken to ER. Was given fluids and released. Felt better after fluids.
tinnitus , ringing in my ears.   constant and continuous.   has not stopped since I received the 1st vaccine shot
Patient briefly passed out after vaccines were given. We gave him water and a cold pack and had him sit with his father for about 30 minutes. Took blood pressure. Pt began to feel better on his own and was able to walk out unassisted.
Had rubella vax on 13FEB92 noticed stiffness of hands & feet w/pain in hands on approx 27FEB92 reported to MD 3MAR92; reported sx had dec in severity;
I got my third shot the booster shot not the second shot; I got my third shot the booster shot not the second shot; Sore arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date were unknown), via an unspecified route of administration on 08Oct2021 as dose 3 (booster), single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore arm on an unknown date. On an unspecified date, the patient experienced I got my third shot the booster shot not the second shot. Consumer stated, "I got an email today saying that, confirming my second COVID dose given yesterday. It was my third dose not my second". Consumer stated, "The sore arm. All I wanna do is get the records straight that I got my third shot the booster shot not the second shot". The outcome of the events were unknown.   The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.
Back and feet pain; drop (right) foot; numbness in left foot; urinary retention; transverse myelitis demyelinated nerve; right foot recovered at about 60 % use w constant pain.
Lt arm swollen & red from shoulder to elbow; no fever; given DPH w/cool compresses;
I had a lot of arm pain for three days after receiving the Moderna Dose 6 vaccine and fatigue. On 05/28/2023, I developed acute joint pain in my left hip. The muscle goes into spasms too. I contacted my doctor, and I was referred to a physical therapist. I have an appointment today.
Says had fever as high as 102. 10 days after injection and developed temper tantrums and not consolable.
Narrative:  59 YO PATIENT received second covid19 vaccine (moderna) on 3/17/21 with the following side effects: low grade fever, chills, body aches, left shoulder at injection site warm and redness radiating down to bicep and getting larger, no pus, area warm painful to touch
The vaccine was administered incorrectly  resulting in joint inflammation and severe pain when moving arm, eventually causing frozen shoulder.
Rash in the form of red blotches at the injection site and also spread along the complete outer side of the upper arm. Blotches are irregular in shape (not circular); slight discomfort (comparable to the feeling of a light sunburn).  No treatment yet (report filed on the first day).
she is breaking out in the full, red-pox all over the place, itching and burning issues.; Breaking out with red bumps all over the place; she is breaking out in the full, red-pox all over the place, itching and burning issues.; she is breaking out in the full, red-pox all over the place, itching and burning issues.; she is breaking out in the full, red-pox all over the place, itching and burning issues.; Breaking out with red bumps all over the place; This is a spontaneous report from a contactable consumer or other non hcp. A 59-years-old female patient (reporter's mother) received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and expiry date was not reported) dose number unknown, via an unspecified route of administration in Arm Left on an unspecified date at 13:00 as single dose for COVID-19 immunisation. Medical history included blood pressure from an unknown date and unknown if ongoing, diabetes from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. No prior vaccination within 4 weeks. On an unspecified date, she is breaking out in the full, red pox all over the place, itching and burning issues and breaking out with red bumps all over the place. Patient got the vaccination shot about a week ago. Reporter stated, was trying to see what she needed to do. Therapeutic measures were not taken as a result of the events. The outcome of the events was unknown.
Patient administered Pfizer Vaccination at 1301; escorted to waiting room for observation, and then reports lightheadedness and nausea. Patient states reported sx's started at 1200 today, prior to receiving vaccination. Patient denies any dietary or fluid intake today.   Patient offered snack - patient declined Patient offered bottle of water - small sips taken   Vitals taken : BP 126/82 HR 92 SpO2 97%   Patient is here today for COVID-19 immunization per federal guidelines/written order. See immunization activity for details. Patient was observed post-immunization for a minimum of 15 minutes without evidence of intolerance, see vitals above. Patient declined additional oberservation of 15 minutes advised by RN.   Patient escorted to waiting area where she made second dose appointment; patient left COVID vaccination office on own, against the request of additional observation for reported sx's   Patient instructions added for patient to review in her online symptom checker account. COVID-19 post-vaccination Patient Instructions added to After Visit Summary for patient to review in her  online symptom checker account.
Joint pains in her knees, hips and back. On March 8th she got Shingles and a few days later she got a terrible outbreak.
Patient has soreness only at injection site that has lasted since his vaccine administration date. No bruising, swelling, redness, etc. Only soreness, and only at localized site of injection--no where else on arm and not shoulder, not whole muscle, just the actual injection site.
patient fainted 5 minutes after receiving vaccines while in clinic. Providers said it was a vasovagal response.
Initial report received from a health care professional on 09 November 2011. A female patient received an intradermal injection (site not reported) of FLUZONE Intradermal, sanofi pasteur lot number not reported, on an unknown date. The patient's medical history was not reported. On an unknown date, the patient had a severe allergic reaction with severe wheezing to the FLUZONE intradermal. The patient required treatment with epinephrine and steroids. The outcome was not reported. Documents held by sender: None.
back pain. could be do to regular work because patient went back to work right away and performed regular lifting duties.
Headache, Fever & Diarrhea Narrative:  Other Relevant History:
Nosebleeds x 3 days following vaccination, which have since resolved.  No treatment needed.  No other side effects reported.
patient is reporting her left arm where she received 2 vaccines made her arm with big red band around it looked about 3 inches in width and very noticeable and warm to touch.
about 15 mins after vaccine, during observation period, patient began to feel weak and had a near syncopal episode.  Resolved with supportive measures.  Juice, water and ice,  Rest and observed for 1 hr after.
experiencing fever 101.3; This is a spontaneous report from a contactable consumer (patient wife). A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 on an unspecified date for covid-19 immunization. The reporter stated that patient received the second dose of the Pfizer vaccine and experiencing fever 101.3 (body temperature). The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
On Wednesday, 5/28/08, at 6pm, patient began running fever of 99 degrees F.  Parents began giving TYLENOL (Infant's).  Fever gradually increased to 101 degrees F by Friday (5-30-08) and patient was lethargic, difficult to awaken & not eating.  Went to ER.
Presented to emergency department on 5/12/21 with productive cough what onset a week and half prior to presentation. Also had complaints of diarrhea, nausea, dizziness, and shortness of breath when standing. Patient had cardiac stent placed approximately 5 weeks earlier. Was found to be COVID-19 positive and was admitted for further management.  He was admitted for 2 days.
3DEC96 seen for bronchitis;18DEC96 c/o dizziness;it was felt that probably had viral labyrinthitis;26DEC96 collapsed on the floor of LMD lobby;also had diarrhea;poss virus;c/o vertigo;MD suspects viral vestibulopathy;SOB, gagging;
First I had a funny taste in my mouth - 2-4 hours after vaccine. 8-9 hours after the injection - I woke up with the first of what would become extremely severe body aches. I took some Aleve - that helped some with the symptoms - but not efficacious. It turned into bone deep pain that made me cry. I would say 7 on the pain scale. That lasted two days. It started slow and then it got big. It was very bad for 12-16 hours. I didn't leave bed and I cried a lot. Worse than childbirth. I was left with another two days after that with some severe fatigue and then I started recovering. About 10 days after vaccine,  on the morning of the 17th, I thought I had a spider bite but it was the beginning of a rather severe shingles outbreak which I haven't had before.  I had a telehealth appt with employee health -  I was treated  with anti-viral - Valtrex generic on the 19th. The rash was mostly gone with the  medicine - everything is scabbed over but the nerve pain is still here to this day. I still missed work this week.
Approx 6 hours after vaccination --numbness and swelling  in face bilaterally.  Dizziness and HA. HA improved at day 3, Still has numbness in left side of face. Still having dizziness.  Body aches
I missed my second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I missed my second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I missed my second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.
At 7 pm that night developed upper back pain that progressed into whole body aches by the middle of the night - lasted for 24 hours. Experienced chills that night as well.
Double pneumonia; Urinary tract infection; Silent heart attack; Delirious; Passed out; Very weak; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DELIRIUM (Delirious), LOSS OF CONSCIOUSNESS (Passed out), PNEUMONIA (Double pneumonia), URINARY TRACT INFECTION (Urinary tract infection) and MYOCARDIAL INFARCTION (Silent heart attack) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history was reported).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DELIRIUM (Delirious) (seriousness criterion hospitalization), LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion hospitalization), PNEUMONIA (Double pneumonia) (seriousness criterion hospitalization), URINARY TRACT INFECTION (Urinary tract infection) (seriousness criterion hospitalization), MYOCARDIAL INFARCTION (Silent heart attack) (seriousness criterion hospitalization) and ASTHENIA (Very weak). At the time of the report, DELIRIUM (Delirious), PNEUMONIA (Double pneumonia), URINARY TRACT INFECTION (Urinary tract infection), MYOCARDIAL INFARCTION (Silent heart attack) and ASTHENIA (Very weak) outcome was unknown and LOSS OF CONSCIOUSNESS (Passed out) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and medical history were not reported. The treatment received in response to the events was unknown.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information was received from a physician concerning a 16 year old male patient. On 05-SEP-2013 the patient was vaccinated with GARDASIL (Lot # J006236, expiration 25-FEB-2016), 0.5 ml, intramuscular. The patient experienced left arm pain after administration of GARDASIL on 05-SEP-2013. "A few days later" the patient developed neck pain. "A few days after that", the patient developed pain in the right arm which then progressed to generalized myalgia and fatigue. The patient was evaluated in the office on 08-OCT-2013. The patient was advised to increase hydration. No further information was provided. Additional information has been requested.
Infant death, diagnosed as Sudden Infant Death Syndrome 02/04/2004 Autopsy report rec'd -- COD was SIDS.
Exactly one week later, 1/12/2021, my left arm where the vaccine was administered swelled up, turned red and scratchy with a defined red line surrounding the swollen area. Was about 6 inches long down my arm and about three inches wide across my arm. It lasted for 4 to 5 days.
Later of the day I got the shot, I started feel flu-like symptoms: fatigue, bodyaches and a fever (about 100 F). I took Tylenol next morning and rested all morning, then I was feeling okay in the afternoon.
**Premedicated 2 hours before vaccine with 50mg Benadryl (25mgx2).**  6:30 PM:"Eyes began to ooze, sore throat" 8:00 PM:"Felt like I had the flu, cough, runny nose, achy and feverish" 12:00 AM:"Middle of the night I woke up and my lips and eyes were swollen, I felt a little short of breath with sores in my mouth"   (This continued through the weekend, and she went to her doctor on Monday)
Extreme fever; chills; vomiting; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration on 19Mar2021 at arm left (at the age of 36-year-old) as a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. In Mar-2021 the patient experienced Extreme fever, chills, vomiting, diarrhoea. The clinical outcome of Extreme fever, chills, vomiting, diarrhea was unknown at the time of report.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Patients Initials updated in First Name field only. Patients Age/Units captured as 36 years per vaccination date=19Mar2021, event's onset and DoB. For all events: Onset captured as Mar2021 per vaccination date=19Mar2021 and PRD=21Mar2021. Please review if need remove It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine from consolidated narrative since not mention this in source. And also for Case id: 24753, it not reported in source. Initial information need review: Covid vaccine details updated
Patient fainted, slumped in chair and seemed shaky. 911 was called immediately and pharmacist mentioned patient. Fire dept and EMS arrived monitored pt for 15+ minutes. Pt then was feeling well, refused ambulance and any more medical attention. Signed a release and walked out of store under his own free will.
DEVELOPED COVID19 OCTOBER 2021, WITH FEVER AND SHORTNESS OF BREATH.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2008, the patient was inoculated at medical center with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended. On or about 01-MAY-2016, the patient was treated and diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Gave one patient 6 full doses of vaccine; she developed persistent conjunctivitis in both eyes; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program (159558).  An adult female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 Immunization; Bnt162b2 (dose 2, single), for COVID-19 Immunization. The following information was reported: OVERDOSE (non-serious), outcome "unknown", described as "Gave one patient 6 full doses of vaccine"; CONJUNCTIVITIS (non-serious), outcome "not recovered", described as "she developed persistent conjunctivitis in both eyes".  Additional information: The age of the patient was reported to be around 50 to 60. Reporter confirms the medical assistant was administering a Covid booster and gave the patient 6 full doses. The patient was fine that day and laughed about it. The doctor's office checked on daily for a week and she had no reports of an adverse event. The medical assistant had never done a Pfizer vaccine before and pulled the whole vial undiluted. He was given instructions and didn't follow them. 6 doses is an odd number to have in a vial and makes it harder to remember. The patient's daughter brought her into the clinic because she developed persistent conjunctivitis in both eyes and blames the vaccine and they were very angry. The patient was vaccinated in doctor's office. The physician does not consider it related to the vaccine based on the literature he read.   Follow-up attempts have been completed; information about lot/batch number cannot be obtained. No further information is expected.
Employee came to my office on 01/04/2021 stating that she received her COVID #1 immunization on 12/24/2020. Later that evening she reports developing a cough, fever, headache, bodyaches, chills and vomiting. Her s/s continued on 12/25/2020 and she reports going to the ED (no record found in to verify this claim) for evaluation. She states a COVID test was ordered (negative results).  She sought further treatment on 12/29/2020 for ongoing symptoms. Another COVID test was ordered (negative results) and a CXR was taken, which the employee states "showed inflammation". I advised her to call her PCP for further follow-up care/evaluation and for advice on receiving her second COVID vaccine.
The patient states that his arm was very painful, and that it got red and was warm feeling. He also states that he was sick for about 4 days following receiving the vaccines. The patient said that he did not go to the doctor or anything for it, and that everything resolved after a few days.